12 Einträge gefunden

1. Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.

   1. Wölber, Linn
   2. Jung, S
   3. Zu Eulenburg, Christine Gräfin
   4. Müller, Volkmar
   5. Schwarz, Jörg
   6. Jänicke, Fritz
   7. Mahner, Sven

   2010 - Forschungsinformationssystem des UKE
2. Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

   1. Henningsen, Maike
   2. Wirtz, R M
   3. Kalogeras, K T
   4. Milde-Langosch, Karin
   5. Schmidt, M
   6. Witzel, Isabell
   7. Eleftheraki, A G

   2010 - Forschungsinformationssystem des UKE
3. Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

   1. Henningsen, Maike
   2. Köhler, N
   3. Kersten, Jan Felix
   4. Milde-Langosch, Karin
   5. Beck, K
   6. Höller, S
   7. Müller, Volkmar

   2010 - Forschungsinformationssystem des UKE - frei zugänglich
4. Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases.

   1. Choschzick, Matthias
   2. Wölber, Linn
   3. Hess, Stephan
   4. Zu Eulenburg, Christine Gräfin
   5. Schwarz, Jörg
   6. Simon, Ronald
   7. Mahner, Sven

   2010 - Forschungsinformationssystem des UKE
5. Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

   1. Schwarz, Jörg
   2. Tiling, R
   3. Avril-Sassen, S
   4. Mahner, Sven
   5. Lebeau, Annette
   6. Weber, Christoph
   7. Schwaiger, M

   2010 - Forschungsinformationssystem des UKE
6. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.

   1. Witzel, Isabell
   2. Milde-Langosch, Karin
   3. Wirtz, Ralph M
   4. Roth, Claudia
   5. Henningsen, Maike
   6. Mahner, Sven
   7. Zu Eulenburg, Christine Gräfin

   2010 - Forschungsinformationssystem des UKE
7. Serum carbonic anhydrase IX during first-line therapy of ovarian cancer.

   1. Wölber, Linn
   2. Müller, Volkmar
   3. Zu Eulenburg, Christine Gräfin
   4. Schwarz, Jörg
   5. Carney, Walter
   6. Jänicke, Fritz
   7. Milde-Langosch, Karin

   2010 - Forschungsinformationssystem des UKE
8. Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer.

   1. Konecny, Gottfried E
   2. Pauletti, Giovanni
   3. Untch, Michael
   4. Wang, He-Jing
   5. Möbus, Volker
   6. Kuhn, Walther
   7. Thomssen, Christoph

   2010 - Forschungsinformationssystem des UKE
9. Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.

   1. Choschzick, Matthias
   2. Lassen, Paula
   3. Lebeau, Annette
   4. Marx, Andreas
   5. Terracciano, Luigi
   6. Heilenkötter, Uwe
   7. Jänicke, Fritz

   2010 - Forschungsinformationssystem des UKE
10. Clinical management of borderline ovarian tumors.

    1. Trillsch, Fabian
    2. Mahner, Sven
    3. Ruetzel, Jd
    4. Harter, P
    5. Ewald-Riegler, N
    6. Jänicke, Fritz
    7. Du Bois, A

    2010 - Forschungsinformationssystem des UKE
11. TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients.

    1. Mahner, Sven
    2. Wölber, Linn
    3. Zu Eulenburg, Christine Gräfin
    4. Schwarz, Jörg
    5. Carney, Walter
    6. Jänicke, Fritz
    7. Milde-Langosch, Karin

    2010 - Forschungsinformationssystem des UKE - frei zugänglich
12. A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer.

    1. Sehouli, Jalid
    2. Camara, Oumar
    3. Mahner, Sven
    4. Bauknecht, Thomas
    5. Lichtenegger, Werner
    6. Runnebaum, Ingo
    7. Look, Katherine

    2010 - Forschungsinformationssystem des UKE